Integrated multi-omics analysis of oligodendroglial tumours identifies three subgroups of 1p/19q co-deleted gliomas
2016 · Nature Communications · 108 citations
https://doi.org/10.1038/ncomms11263
F
Fanny Burel‐Vandenbos
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
167
Papers
4.1K
Citations
36
h-index
63
i10-index
Fanny Burel‐Vandenbos is an academic researcher from Centre Hospitalier Universitaire de Nice. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Sarcoma Diagnosis and Treatment & Neuroblastoma Research and Treatments. The author has an h-index of 36, co-authored 142 publications.
ORCID: 0000-0001-8976-0126Papers by this author
worksCell-based therapy using miR-302-367 expressing cells represses glioblastoma growth
2017 · Cell Death and Disease · 73 citations
https://doi.org/10.1038/cddis.2017.117
TCF12 is mutated in anaplastic oligodendroglioma
2015 · Nature Communications · 70 citations
https://doi.org/10.1038/ncomms8207
A Positive Feed-forward Loop Associating EGR1 and PDGFA Promotes Proliferation and Self-renewal in Glioblastoma Stem Cells
2016 · Journal of Biological Chemistry · 44 citations
https://doi.org/10.1074/jbc.m116.720698
The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma
2018 · PLoS ONE · 43 citations
https://doi.org/10.1371/journal.pone.0193477
<i><scp>EGFR</scp></i>, <i><scp>KRAS</scp></i>, <i><scp>BRAF</scp></i>, and <i><scp>HER</scp>‐2</i> molecular status in brain metastases from 77 <scp>NSCLC</scp> patients
2013 · Cancer Medicine · 36 citations
https://doi.org/10.1002/cam4.82
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat